Logo
PRIMARY BILIARY CHOLANGITIS TREATMENT MARKET ANALYSIS
  2. / Market Insights
  3. Primary Biliary Cholangitis Treatment Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

PRIMARY BILIARY CHOLANGITIS TREATMENT MARKET ANALYSIS

Primary Biliary Cholangitis Treatment Market By Treatment Type (Ursodeoxycholic Acid (UDCA), Obeticholic Acid (Ocaliva), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In : Dec 2023
  • Code : CMI2555
  • Pages :128
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

  • Intercept Pharmaceuticals, Inc.
  • Highlight Therapeutics, S.L.
  • GSK plc.
  • Bristol-Myers Squibb and Company
  • Enanta Pharmaceuticals
  • NW Biotherapeutics
  • Merck & Co Inc.
  • Ipsen Pharma
  • Johnson & Johnson
  • GENFIT
  • Ironwood Pharmaceuticals, Inc.
  • Novartis AG
  • COUR Pharmaceuticals
  • Kaken Pharmaceutical Co., Ltd.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Primary Biliary Cholangitis Treatment Market to Surpass US$ 1,174.1 Mn by 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.